Equities research analysts at StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the ...

Sutro Biopharma (STRO) announced the completion of a strategic portfolio review resulting in the prioritization of its three wholly-owned ...